JPIAMRs Laura Marin presents the article published in the journal Trends in Microbiology on AMR, science policy, innovation, public health and funding. The article summarises the many recent AMR projects (JPIAMR, TATFAR, CARB-X, GARDP, ND4BB , G7/ G20 Health Ministers, and more) and is a good general reference and entry to the AMR community. The article is co-authored by Arjon Van Hengel (Directorate-General for Research & Innovation, European Commission) and Laura Marin (JPIAMR).
JPIAMR is pleased to welcome nine new members to the Scientific Advisory Board, SAB. The new members have diverse experience in the field of AMR, adding key knowledge and experiences to the whole SAB. Now fifthteen members strong.
The following SAB members have been appointed by the JPIAMR Management Board for the period 2019-2021:
For individual biographies and further information, please click here.
JPIAMR will be participating in a high-level meeting in Brussels, on January 17th 2019, on the development of ECRAID, the European Clinical Research Alliance on Infectious Diseases. ECRAID envisages a European-wide sustainable clinical research organization for infectious diseases and AMR, antimicrobial resistance. Laura Marin, JPIAMR Head of Secretariat, will participate in panels, etc.
ECRAID’s vision is to create a coordinated and permanent European clinical research infrastructure for clinical research on infectious diseases. The focus is on two major challenges: emerging infectious diseases with epidemic or pandemic potential, caused by new or re-emerging pathogens, and AMR (antimicrobial resistance). ECRAID will be enable clinical research to be faster and easier having rapid access to and knowledge of developed clinical and laboratory sites. Trials will be conducted continuously to expand on knowledge and experience.
The organisations aim is to protect public health by generating evidence in order to improve diagnosis, prevention, and treatment. The ECRAID mission is to facilitate and develop world class research to protect citizens of Europe against AMR (antimicrobial resistance) and infectious diseases, over the long term. Professor Herman Goossens together with epidemiologist Marc Bonten, is the project coordinators of ECRAID.
There will be panel discussions with clinical research networks, preclinical research networks, pharmaceutical and diagnostic companies,
SMEs, etc. Together with speakers such as EU Commissioner Carlos Moedas, Herman Goossens, Marc Bonten, Magda Chlebus, Executive Director, Science Policy & Regulatory Affairs, EFPIA and Jeremy Farrar, Director of the Wellcome Trust, and others. This is a closed meeting.
In the latest newsletter form EU-JAMRAI, Laura Marin, JPIAMRs Head of Secretariat, is interviewed. The topic is international AMR initiatives and the need of a One Health Approach.
This fits well with JPIAMR’s focus. Our Strategic Research and Innovation Agenda is based on a One Health approach, and the initiatives created by JPIAMR is often centered on global collaboration and coordinating public AMR funding.
The interview was made earlier this year at ECCMID in Spain.
The Call on Diagnostics and Surveillance 2019 will fund joint transnational research projects addressing the development of diagnostic and surveillance tools, technologies and methods to detect antimicrobial resistance (AMR). Projects should address the diagnosis of AMR infections in clinical and veterinary settings, or the surveillance of AMR in humans, animals and the environment. The call promotes projects with impact in low and middle income countries (LMICs) in Asia and Africa.
AMR has become one of the major global health and development challenges of the 21st century. The threat of AMR is particularly high in resource-limited and high-risk settings. This is linked to issues such as weak human and animal health systems; diverse means of food production, processing and consumption; food safety and food security; water, hygiene and sanitation challenges; and the global movement of people and goods.
In response to these challenges, the JPIAMR is pleased to launch this joint transnational call for proposals for innovative research projects on new or improved diagnostic and surveillance strategies, tools, technologies and methods. The call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, such as in LMIC settings in Asia and Africa. Projects are encouraged to use a One Health approach where relevant.
The total call budget is approx. 20 million Euro.
For full information about the call and the application process, please visit the call page.
The two-step application process (pre-proposal, full proposal) will have the following targeted timetable:
| November 15 2018 | Preannouncement: Antibiotic Awareness Day 2018 |
| December 5 2018 | Publication of the JPIAMR ERA-NET 2019 Call |
| February 18 2019 (11:00 CET) | Submission deadline for pre-proposals |
| Mid April 2019 | Full proposal invitations sent to project coordinators |
| June 17th 2019 (11:00 CET) | Submission deadline for full proposals |
| Last week September 2019 | Final funding decision taken by the CSC |
| Mid October 2019 | Final funding decision announced to applicants |
| End of 2019/Early 2020 | Start of funding |
This is the second global conference on AMR that Wellcome Trust is co-hosting, this time together with the governments of Ghana and Thailand and the United Nations Foundation. The conference takes place in Accra on November 19-20. The Call to Action on AMR 2018, is organised in partnership with the Inter-Agency Coordination Group (IACG) on Antimicrobial Resistance, bringing together stakeholders and pioneering projects.
The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) is a growing global collaborative platform, with 27 nations working to curb antibiotic resistance (AMR) with a One Health approach. In that spirit, being a partner is a natural fit.
At the conference, JPIAMR is putting focus on the recently pre-announced AMR Call on Diagnostics and Surveillance. Being included, as a partner in the program and via activities within the conference, the call is communicated together with facts about JPIAMR.
Follow the conference via #CalltoAction18 on Twitter.
JPIAMR is pleased to pre-announce a joint transnational research call for proposals for innovative research projects on new or improved diagnostic and surveillance strategies, tools, technologies and methods. The call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, such as in LMIC settings in Asia and Africa. Projects are encouraged to use a One Health approach where relevant.
The projected call budget is approx. 20 million Euro.
To read more about the call, please click here.
Eight networks have been awarded funding within the JPIAMR 2018 call for transnational networks “Building the Foundation of the JPIAMR Virtual Research Institute.” Each funded network will receive €50,000 to establish expertise clusters to identify research community needs and develop ideas to form the foundation for the JPIAMR Virtual Research Institute (JPIAMR-VRI).
The call was launched in May 2018 and supported by ten research-funding organisations from JPIAMR member countries. Fifteen applications were received, involving 15 coordinators and 323 partners.
To read more on the funded networks, please click here.
Ten networks have been awarded funding within the JPIAMR 7th transnational call: “2018 Network Call on Surveillance”. Each funded network will receive €50,000 to enhance resource alignment and efforts in the field of AMR surveillance.
The call was launched in May 2018 and supported by ten research-funding organisations from JPIAMR member countries. Sixteen applications were received, involving 364 partners from 63 different countries.
To read more on the funded networks, please click here.
Ten projects have been awarded funding within the JPIAMR 6th transnational call: “Innovations against antibiotic-resistant bacteria: New targets, compounds and tools”. The total funding amount is 12,8 M€.
The call was launched in January 2018 and supported by 16 research-funding organisations from JPIAMR member countries. The primary aim of the call is to combine the resources, infrastructures, and research strengths of multiple countries in order to address the identification and validation of new targets, the development of new therapies, and new tools for new treatments (including new antibiotics).
104 applications were received, involving 468 partners. In total ten transnational projects were granted funding.
To read more on the funded projects, please click here.
